Skip to content

It looks like we may have content for your preferred language. Would you like to view this page in English?

Rights Offering for Opexa Therapeutics, Inc.

Represented Maxim Group LLC as lead dealer-manager and National Securities Corporation as co-dealer-manager in a $13.8 million rights offering for Opexa Therapeutics, Inc., a NASDAQ-listed biotechnology company.